BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 35067678)

  • 1. Prevalence and natural history of schwannomas in neurofibromatosis type 2 (NF2): the influence of pathogenic variants.
    Moualed D; Wong J; Thomas O; Heal C; Saqib R; Choi C; Lloyd S; Rutherford S; Stapleton E; Hammerbeck-Ward C; Pathmanaban O; Laitt R; Smith M; Wallace A; Kellett M; Evans G; King A; Freeman S
    Eur J Hum Genet; 2022 Apr; 30(4):458-464. PubMed ID: 35067678
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical features of spinal schwannomas in 65 patients with schwannomatosis compared with 831 with solitary schwannomas and 102 with neurofibromatosis Type 2: a retrospective study at a single institution.
    Li P; Zhao F; Zhang J; Wang Z; Wang X; Wang B; Yang Z; Yang J; Gao Z; Liu P
    J Neurosurg Spine; 2016 Jan; 24(1):145-54. PubMed ID: 26407091
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Schwannomatosis: a genetic and epidemiological study.
    Evans DG; Bowers NL; Tobi S; Hartley C; Wallace AJ; King AT; Lloyd SKW; Rutherford SA; Hammerbeck-Ward C; Pathmanaban ON; Freeman SR; Ealing J; Kellett M; Laitt R; Thomas O; Halliday D; Ferner R; Taylor A; Duff C; Harkness EF; Smith MJ
    J Neurol Neurosurg Psychiatry; 2018 Nov; 89(11):1215-1219. PubMed ID: 29909380
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Earliest clinical manifestations and natural history of neurofibromatosis type 2 (NF2) in childhood: a study of 24 patients.
    Ruggieri M; Iannetti P; Polizzi A; La Mantia I; Spalice A; Giliberto O; Platania N; Gabriele AL; Albanese V; Pavone L
    Neuropediatrics; 2005 Feb; 36(1):21-34. PubMed ID: 15776319
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Distribution of nonvestibular cranial nerve schwannomas in neurofibromatosis 2.
    Fisher LM; Doherty JK; Lev MH; Slattery WH
    Otol Neurotol; 2007 Dec; 28(8):1083-90. PubMed ID: 18043434
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term natural history of neurofibromatosis Type 2-associated intracranial tumors.
    Dirks MS; Butman JA; Kim HJ; Wu T; Morgan K; Tran AP; Lonser RR; Asthagiri AR
    J Neurosurg; 2012 Jul; 117(1):109-17. PubMed ID: 22503123
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Neurofibromatosis type 2].
    Goutagny S; Bouccara D; Bozorg-Grayeli A; Sterkers O; Kalamarides M
    Rev Neurol (Paris); 2007 Sep; 163(8-9):765-77. PubMed ID: 17878803
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phenotypic and genotypic overlap between mosaic NF2 and schwannomatosis in patients with multiple non-intradermal schwannomas.
    Kehrer-Sawatzki H; Kluwe L; Friedrich RE; Summerer A; Schäfer E; Wahlländer U; Matthies C; Gugel I; Farschtschi S; Hagel C; Cooper DN; Mautner VF
    Hum Genet; 2018 Jul; 137(6-7):543-552. PubMed ID: 30006736
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Revisiting the UK Genetic Severity Score for NF2: a proposal for the addition of a functional genetic component.
    Catasús N; Garcia B; Galván-Femenía I; Plana A; Negro A; Rosas I; Ros A; Amilibia E; Becerra JL; Hostalot C; Rocaribas F; Bielsa I; Lazaro Garcia C; de Cid R; Serra E; Blanco I; Castellanos E;
    J Med Genet; 2022 Jul; 59(7):678-686. PubMed ID: 34348961
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rates of loss of heterozygosity and mitotic recombination in NF2 schwannomas, sporadic vestibular schwannomas and schwannomatosis schwannomas.
    Hadfield KD; Smith MJ; Urquhart JE; Wallace AJ; Bowers NL; King AT; Rutherford SA; Trump D; Newman WG; Evans DG
    Oncogene; 2010 Nov; 29(47):6216-21. PubMed ID: 20729918
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neurofibromatosis type 2 in an infant with multiple plexiform schwannomas as first symptom.
    Miyakawa T; Kamada N; Kobayashi T; Hirano K; Fujii K; Sasahara Y; Nagai Y; Shinkai H
    J Dermatol; 2007 Jan; 34(1):60-4. PubMed ID: 17204104
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic aberrations in sporadic and neurofibromatosis 2 (NF2)-associated schwannomas studied by comparative genomic hybridization (CGH).
    Antinheimo J; Sallinen SL; Sallinen P; Haapasalo H; Helin H; Horelli-Kuitunen N; Wessman M; Sainio M; Jääskeläinen J; Carpén O
    Acta Neurochir (Wien); 2000; 142(10):1099-104; discussion 1104-5. PubMed ID: 11129530
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sporadic vestibular schwannoma: a molecular testing summary.
    Sadler KV; Bowers NL; Hartley C; Smith PT; Tobi S; Wallace AJ; King A; Lloyd SKW; Rutherford S; Pathmanaban ON; Hammerbeck-Ward C; Freeman S; Stapleton E; Taylor A; Shaw A; Halliday D; Smith MJ; Evans DG
    J Med Genet; 2021 Apr; 58(4):227-233. PubMed ID: 32576656
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential diagnosis of type 2 neurofibromatosis: molecular discrimination of NF2 and sporadic vestibular schwannomas.
    Wu CL; Thakker N; Neary W; Black G; Lye R; Ramsden RT; Read AP; Evans DG
    J Med Genet; 1998 Dec; 35(12):973-7. PubMed ID: 9863591
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Probability of bilateral disease in people presenting with a unilateral vestibular schwannoma.
    Evans DG; Lye R; Neary W; Black G; Strachan T; Wallace A; Ramsden RT
    J Neurol Neurosurg Psychiatry; 1999 Jun; 66(6):764-7. PubMed ID: 10329751
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multiple Meningiomas as a Criterion for the Diagnosis of Neurofibromatosis Type 2 and Other Tumor Predisposition Syndromes.
    Hannan CJ; Hammerbeck-Ward C; Pathmanaban ON; Smith MJ; Rutherford SA; Lloyd SK; Mackenzie Freeman SR; Wallace AJ; King AT; Richard Evans DG
    Neurosurgery; 2022 Jun; 90(6):793-799. PubMed ID: 35343466
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pediatric cerebellopontine angle and internal auditory canal tumors: clinical article.
    Holman MA; Schmitt WR; Carlson ML; Driscoll CL; Beatty CW; Link MJ
    J Neurosurg Pediatr; 2013 Oct; 12(4):317-24. PubMed ID: 23909617
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Concordance of bilateral vestibular schwannoma growth and hearing changes in neurofibromatosis 2: neurofibromatosis 2 natural history consortium.
    Fisher LM; Doherty JK; Lev MH; Slattery WH
    Otol Neurotol; 2009 Sep; 30(6):835-41. PubMed ID: 19704365
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The neurofibromatosis type 2 gene is inactivated in schwannomas.
    Twist EC; Ruttledge MH; Rousseau M; Sanson M; Papi L; Merel P; Delattre O; Thomas G; Rouleau GA
    Hum Mol Genet; 1994 Jan; 3(1):147-51. PubMed ID: 8162016
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A group of schwannomas with interstitial deletions on 22q located outside the NF2 locus shows no detectable mutations in the NF2 gene.
    Bruder CE; Ichimura K; Tingby O; Hirakawa K; Komatsuzaki A; Tamura A; Yuasa Y; Collins VP; Dumanski JP
    Hum Genet; 1999 May; 104(5):418-24. PubMed ID: 10394935
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.